Understanding Consumer Awareness and Perceptions about Gene Therapy for Hemophilia among EU5 Countries
The objective of the study was to understand how much consumers already know about Gene Therapy (GT) for Hemophilia in order to inform the messaging and positioning strategy for their new drug in the EU5 markets (France, Germany, Italy, Spain, United Kingdom).
Industry : Life Sciences
